Pelthos Therapeutics Inc. (PTHS)

Pelthos Therapeutics Statistics

Total Valuation

PTHS has a market cap or net worth of $77.17 million. The enterprise value is $60.27 million.

Market Cap	77.17M
Enterprise Value	60.27M

Important Dates

The last earnings date was Thursday, November 13, 2025, before market open.

Earnings Date	Nov 13, 2025
Ex-Dividend Date	n/a

Share Statistics

PTHS has 3.09 million shares outstanding. The number of shares has increased by 170.72% in one year.

Current Share Class	3.09M
Shares Outstanding	3.09M
Shares Change (YoY)	+170.72%
Shares Change (QoQ)	+377.97%
Owned by Insiders (%)	5.84%
Owned by Institutions (%)	22.69%
Float	1.22M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	3.79
Forward PS	2.28
PB Ratio	1.20
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	8.14
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 2.01, with a Debt / Equity ratio of 0.06.

Current Ratio	2.01
Quick Ratio	0.90
Debt / Equity	0.06
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-9.66

Financial Efficiency

Return on equity (ROE) is -83.00% and return on invested capital (ROIC) is -42.40%.

Return on Equity (ROE)	-83.00%
Return on Assets (ROA)	-20.64%
Return on Invested Capital (ROIC)	-42.40%
Return on Capital Employed (ROCE)	-20.88%
Revenue Per Employee	$673,273
Profits Per Employee	-$2.14M
Employee Count	11
Asset Turnover	0.12
Inventory Turnover	n/a

Taxes

Income Tax	-465,000
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +323.73% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	+323.73%
50-Day Moving Average	29.28
200-Day Moving Average	21.16
Relative Strength Index (RSI)	45.05
Average Volume (20 Days)	27,014

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, PTHS had revenue of $7.41 million and -$23.58 million in losses. Loss per share was -$19.07.

Revenue	7.41M
Gross Profit	5.13M
Operating Income	-21.23M
Pretax Income	-24.05M
Net Income	-23.58M
EBITDA	n/a
EBIT	-21.23M
Loss Per Share	-$19.07

Balance Sheet

The company has $14.20 million in cash and $3.48 million in debt, giving a net cash position of $10.72 million or $3.47 per share.

Cash & Cash Equivalents	14.20M
Total Debt	3.48M
Net Cash	10.72M
Net Cash Per Share	$3.47
Equity (Book Value)	58.25M
Book Value Per Share	18.85
Working Capital	24.99M

Cash Flow

Operating Cash Flow	-17.01M
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Margins

Gross Margin	69.27%
Operating Margin	-286.65%
Pretax Margin	-324.69%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	-286.65%
FCF Margin	n/a

Dividends & Yields

PTHS does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-170.72%
Shareholder Yield	-170.72%
Earnings Yield	-33.22%
FCF Yield	n/a

Analyst Forecast

The average price target for PTHS is $56.00, which is 124.00% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$56.00
Price Target Difference	124.00%
Analyst Consensus	Strong Buy
Analyst Count	4
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on July 2, 2025. It was a reverse split with a ratio of 1:10.

Last Split Date	Jul 2, 2025
Split Type	Reverse
Split Ratio	1:10

Scores

PTHS has an Altman Z-Score of -0.57 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-0.57
Piotroski F-Score	2